UroGen Pharma Q3 Operating Income $8.329 Million vs. $14.4 Million IBES Estimate
UroGen Pharma reported Q3 operating income of USD 8.329 million, compared with an IBES estimate of USD 14.4 million.
Related stories
MGIC Investment Reports Results for Quarter Ended September 30
L impact | EARNINGS | Nov 05, 2026, 12:16 AM UTC
Zevia Q3 Sales Rise on Volume Growth and Pricing Actions
Zevia reported higher third-quarter sales, citing volume growth and pricing actions.
M impact | EARNINGS | Nov 05, 2026, 12:15 AM UTC
SoftBank Shares Fall 7.9% After Arm Holdings Earnings
H impact | EARNINGS | Nov 05, 2026, 12:15 AM UTC
Gold Royalty Reports Q3 Net Income of USD 3.838 Million
M impact | EARNINGS | Nov 05, 2026, 12:14 AM UTC
MercadoLibre Profit Misses as Shares Fall
MercadoLibre’s profit missed expectations amid logistics spending, and its shares fell.
M impact | EARNINGS | Nov 05, 2026, 12:13 AM UTC
OceanaGold Philippines Reports Quarterly Net Income of $28.3 Million
L impact | EARNINGS | Nov 05, 2026, 12:13 AM UTC